Authors:
Takahashi, N
Li, WW
Banerjee, D
Scotto, KW
Bertino, JR
Citation: N. Takahashi et al., Sequence-dependent enhancement of cytotoxicity produced by ecteinascidin 743 (ET-743) with doxorubicin or paclitaxel in soft tissue sarcoma cells, CLIN CANC R, 7(10), 2001, pp. 3251-3257
Citation: Ra. Johnson et al., Transcriptional repression by p53 through direct binding a novel DNA element, J BIOL CHEM, 276(29), 2001, pp. 27716-27720
Citation: Yx. Lin et al., Optimization of a versatile in vitro transcription assay for the expression of multiple start site TATA-less promoters, BIOCHEM, 40(43), 2001, pp. 12959-12966
Authors:
Jin, S
Gorfajn, B
Faircloth, G
Scotto, KW
Citation: S. Jin et al., Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibitsMDR1 activation, P NAS US, 97(12), 2000, pp. 6775-6779
Authors:
Glick, RD
Medary, I
Aronson, DC
Scotto, KW
Swendeman, SL
La Quaglia, MP
Citation: Rd. Glick et al., The effects of serum depletion and dexamethasone on growth and differentiation of human neuroblastoma cell lines, J PED SURG, 35(3), 2000, pp. 465-472
Authors:
Abolhoda, A
Wilson, AE
Ross, H
Danenberg, PV
Burt, M
Scotto, KW
Citation: A. Abolhoda et al., Rapid activation of MDR1 gene expression in human metastatic sarcoma afterin vivo exposure to doxorubicin, CLIN CANC R, 5(11), 1999, pp. 3352-3356